Anal Cancer | Tumor

CURE’s anal cancer page is an extensive resource of cancer information featuring the latest anal cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on anal cancer.

Three-Drug Regimen Boosts Outcomes in HPV-Related Cancers

January 4th 2023

A novel three-drug combination bested standard-of-care regimens for patients with human papillomavirus-related cancers, according to phase 2 study results.

HPV-Related Cancer Changed My Outlook on Life and Made Me an Advocate for Vaccination

September 21st 2022

Cancer made me more empathetic, as well as an advocate for the HPV vaccine.

I Found My Voice in My Cancer Care and Refused Decisions I Was Uncomfortable With

September 6th 2022

After I was diagnosed with anal cancer, doctors wanted me to get an colostomy bag, but I refused. Later on, I had to voice my concern about a drug that could improve my chances for survival.

Novel Therapy Granted Priority Review By FDA for Treatment of Anal Cancer Subset

January 22nd 2021

The priority review will focus on retifanlimab for the treatment of certain adult patients with locally advanced or metastatic squamous cell carcinoma of the anal canal who did not tolerate platinum-based chemotherapy. Currently, according to Incyte, there are no approved treatments for this patient population.

Anal Cancer: Locking Out an Intruder

August 24th 2020

To halt the rise of anal cancer, everyone eligible needs to be vaccinated against HPV, which causes most cases of the disease.

Cancer Related Clinical Care of Sexual and Fender Minorities

February 25th 2020

Sexual and gender minorities are not receiving the same standard of clinical care as other patients with cancer.

Understanding The Relationship Between HPV and Anal Cancer

February 13th 2020

HPV and Anal cancer are associated with one another, here's what you need to know.

Friday Frontline: June 7, 2019

June 7th 2019

From today’s top entertainers to racial disparities in access to pain treatment, here’s what is making headlines in the cancer space this week.

FDA Approves Age Expansion of HPV Vaccine

October 6th 2018

The Food and Drug Administration (FDA) approved an expanded age indication for GARDASIL 9 (Human Papillomavirus 9-valent Vaccine, Recombinant), according to Merck, the manufacturer of the HPV vaccine.

Driving Research in Rare Cancers

August 7th 2018

Research continues to drive the oncology field.

Down to the Almighty Dollar: Socioeconomic Status Can Affect Cancer Outcomes

July 25th 2018

A recent study found that socioeconomic status can play a role in survival for patients with anal cancer.

NCCN Establishes Guidelines for Treating People With HIV and Cancer

February 27th 2018

Treatment of HIV has drastically improved since the 1980s, but many of these individuals are still facing barriers to proper cancer care.

Immunotherapy Treatment Advances in Anal Cancer

August 3rd 2017

More personalized approaches are being developed to treat patients with metastatic disease.

Despite Benefits, HPV Vaccination Rates Remain Too Low

May 18th 2017

Despite impressive efficacy for the human papillomavirus (HPV) vaccine reducing the prevalence of high-risk oral HPV infections by 88 percent, many young adults still are not getting the vaccine – sparking concern in the health community.

Opdivo Is Promising for Advanced Anal Cancer, Study Shows

April 11th 2017

The PD-1 inhibitor, Opdivo, may be a promising option for patients with advanced anal cancer, according to a recent study.

As HPV-Related Cancer Rates Rise, Vaccination Numbers Remain Low

January 27th 2017

From stigma to convenience, there are many reasons why people do not get the HPV vaccine, although it can prevent some types of cancer. Lois Ramondetta, M.D., discusses updated recommendations and hopes for getting more young people vaccinated.

Encouraging Phase 2 Trial Data Seen With Immunotherapy in Metastatic Anal Cancer

July 12th 2016

Opdivo may be a promising treatment option for patients with squamous cell carcinoma of the anal canal.

HPV Vaccination in Boys Found Cost-Effective in Preventing Oropharyngeal Cancer

April 17th 2015

A new study has shown that vaccinating adolescent boys may be cost-effective for preventing oropharyngeal cancer, a disease that's projected to become the most common HPV-related cancer by 2020.

Study Highlights Geographical Differences in Cervical Cancer Incidence

February 20th 2015

States with the highest incidence of, and mortality from, cervical cancer also have the lowest uptake of the human papillomavirus (HPV) vaccine by adolescent girls, researchers found in a recent study.

NORD Offers Information and Support for Patients of Rare Cancers

November 25th 2014

NORD was founded in 1983 by parents of children with rare diseases. Over the past 30 years, it has become a powerful advocacy voice for all patients with rare diseases, including cancer.

HPV-Related Cancers Rising

March 14th 2013

Cases of HPV-related cancers are on the rise, specifically those associated with head and neck and anal cancers.

Combining Radiation and Chemotherapy May Improve Outcomes

March 13th 2013

In the right cancer, radiation and chemotherapy can make a powerful duo.

Pipeline

March 3rd 2011

The latest in cancer prevention, diagnosis and treatment.

Meetings of the Minds

September 15th 2009

What is multidisciplinary care, and where can patients get it?